Skip to main content
Premium Trial:

Request an Annual Quote

Ned Barnholt, William Sullivan, James Cullen, Jim Richey, Charles Campbell, William Murray, Catherine Burzik, Carl Hull, Stephen Kondor, Peter Dansky

Premium

Agilent Chairman, president and CEO Ned Barnholt will retire at the end of next month, the Palo Alto, Calif.-based firm announced last week.

Barnholt, who has served as CEO for the past six years, will be succeeded by William Sullivan, who currently serves as executive vice president and COO. Sullivan also oversees Agilent’s largest business, the Electronic Products and Solutions Group.

James Cullen, who has served on Agilent’s board of directors since 2000, will take over as non-executive chairman upon Barnholt’s departure.


Lumera announced last week that it has named Jim Richey as senior advisor of business development. In addition, the company named Charles Campbell to its scientific advisory board.

Prior to joining Lumera, Richey held senior executive positions in numerous rapid-growth biotechnology companies, including LJL BioSystems, which was later acquired by Molecular Devices; PerSeptive BioSystems, which was acquired by Applied Biosystems; Pharmacia Biosensor, which is not BIAcore International; and Pharmacia Biotech, which was acquired by Amersham, which is now GE Healthcare.

Campbell is currently co-director of the University of Washington/Pacific Northwest National Laboratory Joint Institute for Nanotechnology. He holds the West Endowed Professorship of Chemistry at the University of Washington. He is editor-in-chief of the journal Surface Science, and has served on the editorial boards of the journals Chemical Physics and Catalysis.


William Murray has been appointed division president, molecular biology at Applied Biosystems. He takes over for Catherine Burzik, the current president of Applied Biosystems, who had been leading the division since the company announced a restructuring last summer.

Murray most recently served as group president of respiratory technologies for Viasys Healthcare. He also has held executive positions at Medtronic

. ABI also announced other management appointments in the molecular biology division, including naming Carl Hull to the post of vice president and general manager, real-time PCR systems and microarrays.

Stephen Kondor was named vice president and general manager, genetic analysis, and Peter Dansky was named senior director and general manager, core PCR and DNA synthesis.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.